Northern Trust Corp Larimar Therapeutics, Inc. Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 365,668 shares of LRMR stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
365,668
Previous 376,458
2.87%
Holding current value
$1.09 Million
Previous $1.44 Million
45.34%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding LRMR
# of Institutions
109Shares Held
64.5MCall Options Held
93.5KPut Options Held
68K-
Deerfield Management Company, L.P. (Series C) New York, NY21.2MShares$63.5 Million1.16% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$18.1 Million0.27% of portfolio
-
Janus Henderson Group PLC London, X05.57MShares$16.7 Million0.01% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.78MShares$14.3 Million5.31% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$10.2 Million6.65% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $129M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...